DK2906286T3 - Sølvnanopladesammensætninger og fremgangsmåder - Google Patents

Sølvnanopladesammensætninger og fremgangsmåder Download PDF

Info

Publication number
DK2906286T3
DK2906286T3 DK13845112.5T DK13845112T DK2906286T3 DK 2906286 T3 DK2906286 T3 DK 2906286T3 DK 13845112 T DK13845112 T DK 13845112T DK 2906286 T3 DK2906286 T3 DK 2906286T3
Authority
DK
Denmark
Prior art keywords
solution
silver
optical density
nanoplates
preconcentrated
Prior art date
Application number
DK13845112.5T
Other languages
English (en)
Inventor
Martin G Miranda
David S Sebba
Todd J Harris
Steven J Oldenburg
Original Assignee
Nanocomposix Inc
Sienna Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50475524&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2906286(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nanocomposix Inc, Sienna Biopharmaceuticals Inc filed Critical Nanocomposix Inc
Application granted granted Critical
Publication of DK2906286T3 publication Critical patent/DK2906286T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/05—Metallic powder characterised by the size or surface area of the particles
    • B22F1/054—Nanosized particles
    • B22F1/0545—Dispersions or suspensions of nanosized particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/05—Metallic powder characterised by the size or surface area of the particles
    • B22F1/054—Nanosized particles
    • B22F1/0551—Flake form nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/14—Treatment of metallic powder
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/14—Treatment of metallic powder
    • B22F1/145—Chemical treatment, e.g. passivation or decarburisation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/14—Treatment of metallic powder
    • B22F1/145—Chemical treatment, e.g. passivation or decarburisation
    • B22F1/147—Making a dispersion
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/16—Metallic particles coated with a non-metal
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G5/00—Compounds of silver
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/20—Compounding polymers with additives, e.g. colouring
    • C08J3/205—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase
    • C08J3/2053—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the additives only being premixed with a liquid phase
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/02—Elements
    • C08K3/08—Metals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/28—Nitrogen-containing compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/34—Silicon-containing compounds
    • C08K3/36—Silica
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/38—Boron-containing compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C08K5/092—Polycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/15—Heterocyclic compounds having oxygen in the ring
    • C08K5/151—Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1535—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D125/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring; Coating compositions based on derivatives of such polymers
    • C09D125/02—Homopolymers or copolymers of hydrocarbons
    • C09D125/04—Homopolymers or copolymers of styrene
    • C09D125/06—Polystyrene
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D129/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical; Coating compositions based on hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Coating compositions based on derivatives of such polymers
    • C09D129/02—Homopolymers or copolymers of unsaturated alcohols
    • C09D129/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D139/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Coating compositions based on derivatives of such polymers
    • C09D139/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
    • C09D139/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/06—Metallic powder characterised by the shape of the particles
    • B22F1/068—Flake-like particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F2301/00—Metallic composition of the powder or its coating
    • B22F2301/25—Noble metals, i.e. Ag Au, Ir, Os, Pd, Pt, Rh, Ru
    • B22F2301/255—Silver or gold
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F2998/00—Supplementary information concerning processes or compositions relating to powder metallurgy
    • B22F2998/10—Processes characterised by the sequence of their steps
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2325/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring; Derivatives of such polymers
    • C08J2325/18—Homopolymers or copolymers of aromatic monomers containing elements other than carbon and hydrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2329/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical; Hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Derivatives of such polymer
    • C08J2329/02—Homopolymers or copolymers of unsaturated alcohols
    • C08J2329/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/02—Elements
    • C08K3/08—Metals
    • C08K2003/0806—Silver

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)
  • Powder Metallurgy (AREA)

Claims (16)

1. Fremgangsmåde til fremstilling af koncentrerede sølvnanoplader i en opløsning, der bevarer form efter opkoncentrering, mens opløsningens optiske densitet øge, hvilken fremgangsmåde omfatter: tilsætning af et stabiliseringsmiddel til en forkoncentreret opløsning, hvor den forkoncentrerede opløsning omfatter sølvnanoplader, hvor hver af sølvnanoplademe har en pladeform, hvor den forkoncentrerede opløsning har en maksimal optisk densitet ved en første bølgelængde; hvor stabiliseringsmidlet omfatter en polyvinyl-baseret polymer og et borat; og øgning af en koncentration af sølvnanoplademe i den forkoncentrerede opløsning, ved anvendelse af centrifugering, fordampning, filtrering, dialyse eller filtrering med krydsende strømning, for at generere en koncentreret opløsning, hvor den forkoncentrerede opløsning har en maksimal optisk densitet ved en første bølgelængde, hvor den koncentrerede opløsning har en maksimal optisk densitet ved en anden bølgelængde, hvor den koncentrerede opløsnings maksimale optiske densitet er større end 10 cm"1, og hvor den koncentrerede opløsnings maksimale optiske densitet er større end den forkoncentrerede opløsnings maksimale optiske densitet, og hvor mindst 50 % af sølvnanoplademe i den forkoncentrerede opløsning bevarer pladcformcn i den koncentrerede opløsning.
2. Fremgangsmåde ifølge krav 1, hvor øgning af koncentrationen udføres ved anvendelse af filtrering med krydsende strømning, hvor den koncentrerede opløsnings maksimale optiske densitet er mindst ti gange større end den forkoncentrerede opløsnings maksimale optiske densitet, hvor den koncentrerede opløsnings maksimale optiske densitet er mindst 100 cm"1, hvor den polyvinyl-baserede polymer omfatter mindst en fra gruppen bestående af: en polyvinylpyrrolidon (PVP) og en polyvinylalkohol (PVA), hvor boratet omfatter natriumborat.
3. Fremgangsmåde ifølge krav 1 eller krav 2, hvor bølgelængden for den koncentrerede opløsnings maksimale optiske densitet ligger i et interval mellem 500 nm og 1500 nm, og hvor bølgelængden for den forkoncentrerede opløsnings maksimale optiske densitet i alt væsentligt er den samme som bølgelængden for den koncentrerede opløsnings maksimale optiske densitet, hvor mindst én optisk egenskab for den koncentrerede opløsning i alt væsentligt er den samme som den forkoncentrerede opløsning, idet den forkoncentrerede opløsnings maksimale optiske densitet og den koncentrerede opløsnings maksimale optiske densitet ligger ved i alt væsentligt den samme bølgelængde.
4. Fremgangsmåde ifølge et hvilket som helst af kravene 1 - 3, hvor sølvnanoplademe fremstilles via en seed-medieret vækstmekanisme, hvor den seed-medierede vækstmekanisme omfatter: kombinering af citrat, polystyrennatriumsulfonat (PSSS) og natriumborhydrid i en første opløsning, tilsætning af sølvnitrat til den første opløsning for at danne en seed-opløsning, tilsætning af en del af seed-opløsningen til en anden opløsning, hvor den anden opløsning omfatter ascorbinsyre, og tilsætning af sølvnitrat til den anden opløsning for at danne den forkoncentrerede opløsning.
5. Fremgangsmåde ifølge krav 1, hvor øgning af koncentrationen udføres ved anvendelse af filtrering med krydsende strømning, hvor der ved filtrering med krydsende strømning anvendes en filtermembran med porer med en molekylvægtgrænse i et interval mellem 10 kDa og 0,05 mikron, hvor den koncentrerede opløsnings maksimale optiske densitet er mindst ti gange større end den forkoncentrerede opløsnings maksimale optiske densitet, hvor den koncentrerede opløsnings maksimale optiske densitet er mindst 100 cm1, og/eller hvor forkoncentreret opløsning centrifugeres efter øgning af koncentrationen ved anvendelse af filtrering med krydsende strømning.
6. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, der endvidere omfatter coating af sølvnanoplademe med silica, hvor coating af sølvnanoplademe med silica omfatter: tilsætning af ethanol til den forkoncentrerede opløsning, tilsætning af en base til den forkoncentrerede opløsning og tilsætning af en silan til den forkoncentrerede opløsning.
7. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor stabiliseringsmidlet omfatter mindst et fra gruppen bestående af: en polyvinylpyrrolidon (PVP), en polyvinylalkohol (PVA) og en polyethylenglycol (PEG).
8. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, der endvidere omfatter dannelse af en metaloxidkappe på overfladen af sølvnanopladen, og fortrinsvis hvor metaloxidkappen er en hvilken som helst fra gruppen bestående af: en silicakappe og en titandioxidkappe, hvor metaloxidkappen har en tykkelse i et interval mellem 1 nm til 100 nm.
9. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor stabiliseringsmidlet endvidere omfatter en kemisk thiolgruppe, og fortrinsvis hvor den kemiske thiolgruppe omfatter mindst en fra gruppen bestående af: en liponsyre, en mercaptohexadecansyre, en mercaptoundecansyre og en dihydroliponsyre.
10. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor delen af de koncentrerede sølvnanoplader, der bevarer pladeformen efter øgning af koncentrationen, er større end 80 % eller større end 90 %.
11. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor den forkoncentrerede opløsning inkuberes med et substrat, hvor substratet omfatter en fiber.
12. Sammensætning, der omfatter: en flerhed af sølvnanoplader i en opløsning, der omfatter en optisk densitet, hvor sølvnanoplademe omfatter en coating på en overflade af sølvnanoplademe, hvor den optiske densitet er større end 100 cm"1, og hvor coatingen omfatter et borat og mindst ét middel, der er udvalgt fra gruppen bestående af: en polyvinyl-baseret polymer og et thiol-holdigt molekyle.
13. Sammensætning ifølge krav 12, hvor boratet omfatter mindst en fra gruppen bestående af: et natriumborat og et kaliumtetraborat.
14. Sammensætning ifølge krav 12 eller krav 13, hvor coatingen omfatter den polyvinyl-baserede polymer, hvor den polyvinyl-baserede polymer er udvalgt fra gruppen bestående af: en polyvinylpyrrolidon (PYP) og en polyvinylalkohol (PVA).
15. Sammensætning ifølge et hvilket som helst af kravene 12 - 14, hvor coatingen omfatter det thiol-holdige molekyle, hvor det thiol-holdige molekyle omfatter mindst en fra gruppen bestående af: en liponsyre, en mercaptohexadecansyre, en mercaptoundecansyre og en dihydroliponsyre.
16. Sammensætning ifølge et hvilket som helst af kravene 12-15, hvor coatingen endvidere omfatter en metaloxidkappe, og fortrinsvis hvor metaloxidkappen er en hvilken som helst fra gruppen bestående af: en silicakappe og en titandioxidkappe, hvor metaloxidkappen har en tykkelse i et interval mellem 1 nm til 100 nm.
DK13845112.5T 2012-10-11 2013-10-08 Sølvnanopladesammensætninger og fremgangsmåder DK2906286T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261795149P 2012-10-11 2012-10-11
PCT/US2013/063920 WO2014058904A1 (en) 2012-10-11 2013-10-08 Silver nanoplate compositions and methods

Publications (1)

Publication Number Publication Date
DK2906286T3 true DK2906286T3 (da) 2017-07-17

Family

ID=50475524

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13845112.5T DK2906286T3 (da) 2012-10-11 2013-10-08 Sølvnanopladesammensætninger og fremgangsmåder

Country Status (16)

Country Link
US (8) US9249334B2 (da)
EP (2) EP3272388A1 (da)
JP (3) JP6325552B2 (da)
KR (2) KR20200106984A (da)
CN (2) CN104822412B (da)
AU (6) AU2013329450B2 (da)
BR (1) BR112015008063A2 (da)
CA (1) CA2887687A1 (da)
DK (1) DK2906286T3 (da)
ES (1) ES2629903T3 (da)
HK (1) HK1254167A1 (da)
IL (6) IL311688B2 (da)
MX (1) MX2015004524A (da)
PL (1) PL2906286T3 (da)
RU (1) RU2646809C2 (da)
WO (1) WO2014058904A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
PT3213738T (pt) 2010-08-27 2020-03-31 Sebacia Inc Composições e métodos para modulação térmica direcionada
FI3489685T3 (fi) 2011-11-21 2023-12-21 Zoetis Services Llc Signaalin vahvistaminen lateraalivirtaus- ja vastaavissa immunomäärityksissä
DK2785310T3 (da) * 2011-11-30 2018-01-29 Institució Catalana De Recerca I Estudis Avançats Fremgangsmåde til øget fotoepilering baseret på metalliske nanopartikler.
AU2013329450B2 (en) * 2012-10-11 2017-06-22 Coronado Aesthetics, Llc Silver nanoplate compositions and methods
CA2889423A1 (en) * 2012-10-26 2014-05-01 Nanocomposix, Inc. Metastable silver nanoparticle composites
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
US11111396B2 (en) 2014-10-17 2021-09-07 C3 Nano, Inc. Transparent films with control of light hue using nanoscale colorants
CA2991532C (en) 2015-08-04 2024-03-05 Abaxis, Inc. Signal amplification in solution-based plasmonic specific-binding partner assays
US9962443B2 (en) 2015-09-16 2018-05-08 LA JOLLA NANOMEDICAL. Inc. Cellular activity targeted nanoparticle system and methods of producing the nanoparticle system
US10147512B2 (en) 2015-12-09 2018-12-04 C3Nano Inc. Methods for synthesizing silver nanoplates and noble metal coated silver nanoplates and their use in transparent films for control of light hue
CN106601914B (zh) * 2016-12-22 2018-11-09 东南大学 一种多晶超薄金属薄膜及二维纳米图形的制备方法
CN118275398A (zh) 2017-01-30 2024-07-02 硕腾服务有限责任公司 基于溶液的等离子体振子特异性结合配偶体测定和金属纳米结构
CN107184981A (zh) * 2017-06-08 2017-09-22 浙江大学 一种片状三角形银纳米粒抗菌悬浮液及其制备方法和应用
CN107414069B (zh) * 2017-08-07 2019-03-12 国家纳米科学中心 银纳米圆片、其制备方法及采用其制备的金纳米环和组装体
WO2019051826A1 (zh) * 2017-09-18 2019-03-21 深圳大学 用于探测芳香辅酶 nad+/nadh 的表面增强拉曼散射基底及其制备方法和应用
CN107716944B (zh) * 2017-10-31 2019-10-08 长春黄金研究院有限公司 化学法制备纳米级片状银粉的方法
CN108188386B (zh) * 2017-12-25 2019-10-15 西安交通大学 一种表面洁净的超薄Ag纳米片及其制备方法
CN108594341B (zh) * 2018-06-13 2020-08-04 中国工程物理研究院应用电子学研究所 金纳米片-金纳米球二聚体的制备及其在强偏振依赖法诺共振的应用
US10967197B2 (en) 2018-08-29 2021-04-06 Azulite, Inc. Phototherapy devices and methods for treating truncal acne and scars
CN109434129B (zh) * 2018-11-01 2021-06-25 首都师范大学 一种制备Au@SiO2@Ag三层核壳构造的复合纳米颗粒的方法
CN109500405B (zh) * 2019-01-17 2022-02-22 鲁东大学 一种三角银纳米片的制备方法
US20220072535A1 (en) * 2019-04-30 2022-03-10 Hewlett-Packard Development Company, L.P. Microfluidic devices
US12515253B2 (en) * 2019-05-06 2026-01-06 Basf Se Compositions, comprising silver nanoplatelets
JP7212370B2 (ja) * 2019-05-28 2023-01-25 Ｃｄｍインフラ環境株式会社 近赤外域のプラズモン吸収をもつナノ粒子の製造方法
CN110143609B (zh) * 2019-05-30 2021-12-14 上海理工大学 一种基于直接沉淀法合成纳米氧化锌形貌可控的制备方法
WO2022031537A1 (en) * 2020-08-03 2022-02-10 Reed Frank Joseph Compositions for prevention and treatment of rsv and coronavirus infection
CN112299936B (zh) * 2020-11-06 2021-09-17 西南科技大学 用于炸药激光引爆的光热材料的制备方法及应用
US20240287281A1 (en) 2021-05-12 2024-08-29 Basf Se Compositions, comprising platelet-shaped transition metal particles
CN113714500B (zh) * 2021-09-18 2023-07-11 浙江希维纳米科技有限公司 超细银纳米线的提纯方法
CN114042929A (zh) * 2021-10-26 2022-02-15 西安交通大学 一种高浓度银纳米-微米片及其合成方法
CN114160785B (zh) * 2021-11-17 2024-01-26 武汉船用电力推进装置研究所（中国船舶重工集团公司第七一二研究所） 一种温和条件可控纳米银溶液的制备方法
CN115364118B (zh) * 2022-09-23 2023-08-25 上海交通大学医学院附属第九人民医院 含银微载体及其在伤口愈合中的应用
CN116079064A (zh) * 2023-01-18 2023-05-09 南京航空航天大学 一种三维结构过渡金属催化剂的制备方法及应用
LU508167B1 (en) * 2024-09-03 2026-03-03 Duck Tech Ab NIR-blocking coating compositions and articles coated with said coating compositions
WO2026041621A1 (en) * 2024-08-20 2026-02-26 Duck Technologies Ab Nir-blocking coating compositions and articles coated with said coating compositions

Family Cites Families (386)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1325730A (en) 1919-12-23 Buffer for automobiles
US1317245A (en) 1919-09-30 Threading attachment
US1167462A (en) 1912-09-16 1916-01-11 Wilson Remover Company Finish-remover and process of making same.
US1185242A (en) 1912-12-09 1916-05-30 Akron Cultivator Company Fertilizer-distributing attachment for cultivators.
US1112325A (en) 1913-07-09 1914-09-29 Richard W Roberts Shipping-box for umbrellas and canes.
US1208005A (en) 1914-09-11 1916-12-12 Thomas L Reed Mail-box.
US1267801A (en) 1915-10-15 1918-05-28 Pfanstiehl Company Inc Process for welding tungsten ingots.
US1210600A (en) 1915-10-22 1917-01-02 Cap Hold Inc Cap-retainer for deformable tubes.
US1201219A (en) 1915-10-25 1916-10-10 Spray Engineering Co Mechanism for applying coating to shrapnel-shells and other articles.
US1263447A (en) 1916-10-07 1918-04-23 Frank L Mcconnel Saw-setting tool.
US1267747A (en) 1917-04-26 1918-05-28 John C Forster Tile-arch construction.
US1506763A (en) 1918-12-31 1924-09-02 Westinghouse Electric & Mfg Co Field-coil collar
US1559393A (en) 1920-02-19 1925-10-27 Naugatuck Chem Co Process for treating rubber and similar materials and to the products obtained thereby
US1502574A (en) 1921-01-03 1924-07-22 Kylin Oskar Adjustable reamer
US1506765A (en) 1921-05-17 1924-09-02 Western Electric Co System for controlling the speed of dynamo-electric machinery
US1506764A (en) 1921-07-09 1924-09-02 Western Electric Co Apparatus for and method of recording the temperature and humidity of the atmosphere
US1506766A (en) 1922-12-11 1924-09-02 Frederick S Mccullough Diffusion pump
US1559394A (en) 1923-05-04 1925-10-27 Josiah H Williams Mold for making glass sign plates
US1529513A (en) 1924-04-08 1925-03-10 Swan Fred Fishing tool for wells
US1677843A (en) 1925-02-04 1928-07-17 Parkin Albert Samuel Door hinge and support
US1744789A (en) 1926-09-15 1930-01-28 Max C Miller Knitting machine
US1768749A (en) 1928-01-09 1930-07-01 Vito Louis De Machine for making flat noodles
US1861465A (en) 1931-02-28 1932-06-07 Westinghouse Electric & Mfg Co Conveyer slot seal
US1959914A (en) 1932-08-03 1934-05-22 George Wellington Abbey Mold-cap filler bar for intertype casting machines
US2231283A (en) 1937-07-29 1941-02-11 Jacques Wolf & Company Manufacture of irish moss
US2343047A (en) 1942-07-29 1944-02-29 Int Paper Co Web severing and transfer device
US2396010A (en) 1944-05-12 1946-03-05 Nathaniel Shapiro Novelty carton
US2416752A (en) 1945-07-20 1947-03-04 John M Hendrick Wheeled suitcase
US2885366A (en) * 1956-06-28 1959-05-05 Du Pont Product comprising a skin of dense, hydrated amorphous silica bound upon a core of another solid material and process of making same
US3905167A (en) 1973-11-09 1975-09-16 Berne A Watkins Modularized building system
GB2052805B (en) 1979-06-29 1983-03-09 Smiths Industries Ltd Gas-turbine engine control
JPS58217599A (ja) 1982-06-10 1983-12-17 花王株式会社 漂白洗浄剤組成物
FR2627388B1 (fr) 1988-02-18 1991-06-14 Roussel Uclaf Nouvelles compositions cosmetiques destinees a combattre la cellulite
FR2649888B1 (fr) 1989-07-18 1994-08-26 Exsymol Sa Produits pour applications cutanees, a effets cosmetiques ou/et therapeutiques
WO1991006894A1 (en) 1989-10-18 1991-05-16 Research Corporation Technologies, Inc. Plasmon enhanced photo processes
US5409797A (en) 1991-03-04 1995-04-25 Fuji Photo Film Co., Ltd. Heat-sensitive recording material for laser recording
FR2677246B1 (fr) 1991-06-04 1995-02-24 Oreal Utilisation de nanopigments d'oxydes metalliques pour proteger la keratine des cheveux contre les agressions atmospheriques, et composition gelifiee utilisant ces nanopigments.
FR2677543B1 (fr) 1991-06-13 1993-09-24 Oreal Composition cosmetique filtrante a base d'acide benzene 1,4-di(3-methylidene-10-camphosulfonique) et de nanopigments d'oxydes metalliques.
FR2677544B1 (fr) 1991-06-14 1993-09-24 Oreal Composition cosmetique contenant un melange de nanopigments d'oxydes metalliques et de pigments melaniques.
US5385729A (en) 1991-08-01 1995-01-31 Colgate Palmolive Company Viscoelastic personal care composition
FR2680684B1 (fr) 1991-08-29 1993-11-12 Oreal Composition cosmetique filtrante comprenant un nanopigment d'oxyde metallique et un polymere filtre.
US5713845A (en) 1991-10-29 1998-02-03 Thermolase Corporation Laser assisted drug delivery
US5817089A (en) 1991-10-29 1998-10-06 Thermolase Corporation Skin treatment process using laser
US5226907A (en) 1991-10-29 1993-07-13 Tankovich Nikolai I Hair removal device and method
US5752948A (en) 1991-10-29 1998-05-19 Thermolase Corporation Hair removal method
US5425728A (en) 1991-10-29 1995-06-20 Tankovich; Nicolai I. Hair removal device and method
US5752949A (en) 1991-10-29 1998-05-19 Thermolase Corporation Hair removal method
US5423803A (en) 1991-10-29 1995-06-13 Thermotrex Corporation Skin surface peeling process using laser
US6132392A (en) 1991-11-27 2000-10-17 Stone; Ross G. Tension headache reliever with multiple pain relieving modalities
US5562643A (en) 1992-12-28 1996-10-08 Johnson; James B. Device and treatment for treatment of skin
FR2700952B1 (fr) 1993-01-29 1995-03-17 Oreal Nouvelles compositions cosmétiques ou dermopharmaceutiques sous forme de gels aqueux modifiés par addition de microsphères expansées.
EG20471A (en) 1993-07-12 1999-05-31 Thermotrex Corp Hair removal device and method
FR2712188B1 (fr) 1993-11-08 1996-01-26 Oreal Composition cosmétique destinée au maquillage de la peau, son procédé de préparation et produit de maquillage obtenu à partir de ladite composition.
US5647866A (en) 1993-11-09 1997-07-15 Zaias; Nardo Method of hair depilation
DE4344141C1 (de) 1993-12-20 1995-07-13 Coiffeur Consulting Team Elect Kosmetisches Produkt zur spezifischen Haarpflege
FR2715843B1 (fr) 1994-02-09 1996-04-12 Oreal Compositions cosmétiques antisolaires, procédé de préparation et utilisation.
US5423337A (en) 1994-03-24 1995-06-13 Ahlert; Gary Medicated dental floss
US5597519A (en) 1994-06-10 1997-01-28 Johnson & Johnson Vision Products, Inc. Ultraviolet cycling oven for polymerization of contact lenses
CA2131750C (en) 1994-07-26 2000-11-21 Thermolase Corporation Improved hair removal method
FR2727312B1 (fr) 1994-11-24 1997-05-23 Oreal Composition cosmetique sous forme de poudre compacte et procede de preparation
ATE252894T1 (de) * 1995-01-05 2003-11-15 Univ Michigan Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
FR2731153B1 (fr) 1995-03-03 1997-04-11 Oreal Composition cosmetique sous forme de dispersion solide comprenant une phase grasse, un alcool polyhydrique et des charges
US20020009488A1 (en) 1995-05-03 2002-01-24 Polymasc Pharmaceuticals Plc Tissue entrapment
EP0753295B1 (fr) 1995-07-13 1998-04-08 L'oreal Utilisation de particules creuses déformables contre le photobleuissement et/ou le blanchiment d'une composition cosmétique et/ou dermatologique contenant des pigments d'oxyde de titane
US6143287A (en) 1996-02-27 2000-11-07 New York Blood Center, Inc. Method and composition for hair removal
FR2746302B1 (fr) 1996-03-20 1998-12-24 Oreal Compositions cosmetiques comprenant des nanopigments
US5655547A (en) 1996-05-15 1997-08-12 Esc Medical Systems Ltd. Method for laser surgery
US5759767A (en) 1996-10-11 1998-06-02 Joseph R. Lakowicz Two-photon and multi-photon measurement of analytes in animal and human tissues and fluids
US5830177A (en) 1996-11-22 1998-11-03 Anticancer, Inc. Skin vibration method for topical targeted delivery of beneficial agents into hair follicles
US6050990A (en) 1996-12-05 2000-04-18 Thermolase Corporation Methods and devices for inhibiting hair growth and related skin treatments
US5810801A (en) 1997-02-05 1998-09-22 Candela Corporation Method and apparatus for treating wrinkles in skin using radiation
US7625420B1 (en) 1997-02-24 2009-12-01 Cabot Corporation Copper powders methods for producing powders and devices fabricated from same
US20020132045A1 (en) 2000-09-27 2002-09-19 Halas Nancy J. Method of making nanoshells
US7144627B2 (en) 1997-03-12 2006-12-05 William Marsh Rice University Multi-layer nanoshells comprising a metallic or conducting shell
US6344272B1 (en) 1997-03-12 2002-02-05 Wm. Marsh Rice University Metal nanoshells
US20020061363A1 (en) 2000-09-27 2002-05-23 Halas Nancy J. Method of making nanoshells
US6852252B2 (en) 1997-03-12 2005-02-08 William Marsh Rice University Use of metalnanoshells to impede the photo-oxidation of conjugated polymer
US5935596A (en) 1997-03-20 1999-08-10 Chesebrough-Pond's Usa Co. Delivery of skin benefit agents via adhesive strips
JP3570730B2 (ja) 1997-04-18 2004-09-29 昭和電工株式会社 化粧料、シリカ被覆金属酸化物粉およびその製法
US6235270B1 (en) 1997-04-18 2001-05-22 Showa Denko K.K. Cosmetics, silica-coated metal oxide powder and production method therefor
FR2762504B1 (fr) 1997-04-29 1999-09-10 Cird Galderma Procede d'epilation
US6165440A (en) 1997-07-09 2000-12-26 Board Of Regents, The University Of Texas System Radiation and nanoparticles for enhancement of drug delivery in solid tumors
US6168590B1 (en) 1997-08-12 2001-01-02 Y-Beam Technologies, Inc. Method for permanent hair removal
US6147982A (en) 1997-12-30 2000-11-14 Ericsson, Inc. System and method for synchronizing acquisition for a code modulated communication system
US6699724B1 (en) 1998-03-11 2004-03-02 Wm. Marsh Rice University Metal nanoshells for biosensing applications
US6428811B1 (en) 1998-03-11 2002-08-06 Wm. Marsh Rice University Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
FR2779637B1 (fr) 1998-06-15 2000-09-01 Oreal Compositions cosmetiques photoprotectrices, contenant un nanopigment d'oxyde metallique et un terpolymere acrylique et utilisation de ces compositions pour proteger les matieres keratiniques contre le rayonnement ultraviolet
FR2780408B1 (fr) 1998-06-25 2000-07-28 Oreal Composition anhydre, utilisation en cosmetique, pharmacie ou hygiene
FR2780282B1 (fr) 1998-06-25 2001-04-13 Oreal Composition anhydre, utilisation en cosmetique, pharmacie ou hygiene
US6645464B1 (en) 1998-07-30 2003-11-11 James F. Hainfeld Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
DE19834819A1 (de) 1998-08-01 2000-02-03 Beiersdorf Ag Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl
US6838088B2 (en) 1998-09-18 2005-01-04 Beiersdorf Ag Emulsifier-free finely disperse systems of the oil-in-water- and water-in-oil- type
DE19842787A1 (de) 1998-09-18 2000-03-23 Beiersdorf Ag Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl
DE19842732A1 (de) 1998-09-18 2000-03-23 Beiersdorf Ag Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl
DE19842767A1 (de) 1998-09-18 2000-03-23 Beiersdorf Ag Emulgatorfreie feindisperse Systeme von Typ Öl-in-Wasser und Wasser-in-Öl
DE19842730A1 (de) 1998-09-18 2000-03-23 Beiersdorf Ag Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl
BR9804597A (pt) 1998-11-10 2000-05-30 Cosmeticos Natural Ind Com Composição cosmética sob a forma de pó.
CA2356705A1 (en) 1998-11-20 2000-06-02 The General Hospital Corporation Permanent, removable tissue markings
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US6283956B1 (en) 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US6676655B2 (en) 1998-11-30 2004-01-13 Light Bioscience L.L.C. Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen
FR2787023A1 (fr) 1998-12-11 2000-06-16 Oreal Utilisation d'un compose indigoide dans une composition cosmetique, notamment de maquillage, pour lui conferer des proprietes anti-microbiennes et de longue tenue.
US6238650B1 (en) 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
US6344050B1 (en) 1998-12-21 2002-02-05 Light Sciences Corporation Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
CO5150202A1 (es) 1998-12-31 2002-04-29 Kimberly Clark Co Composicion de tisu facial y metodo para usarla para el secuestro de irritantes de la piel de la secrecion nasal
US6183773B1 (en) 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
CN1312233C (zh) 1999-01-11 2007-04-25 昭和电工株式会社 化妆料、表面疏水化二氧化硅被覆金属氧化物粒子、二氧化硅被覆金属氧化物溶胶、以及它们的制法
US6491929B1 (en) 1999-03-01 2002-12-10 The General Hospital Corporation Skin cosmetics
FR2790386B1 (fr) 1999-03-04 2001-04-13 Oreal Composition cosmetique sous forme de poudre comprenant un ester particulier
FR2792191B1 (fr) 1999-04-16 2004-04-30 Oreal Composition cosmetique comprenant l'association d'un ester particulier et d'un compose silicone
WO2000064537A1 (en) 1999-04-27 2000-11-02 The General Hospital Corporation Doing Business As Massachusetts General Hospital Phototherapy method for treatment of acne
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
EP1066825A1 (en) 1999-06-17 2001-01-10 The Procter & Gamble Company An anti-microbial body care product
FR2795079B1 (fr) 1999-06-18 2001-08-03 Oreal Gel aqueux solide comprenant un gelifiant hydrophile et un polyethylene glycol particulier, composition comprenant ce gel et utilisations
WO2001005586A1 (en) 1999-07-16 2001-01-25 Wm. Marsh Rice University Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
DE60027578T2 (de) 1999-07-16 2007-01-25 WM. Marsh Rice University, Houston Verfahren zum Nachweis von Bioanalyten unter Verwendung metallischer Nanohüllen
US20030078499A1 (en) 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
US6355054B1 (en) 1999-11-05 2002-03-12 Ceramoptec Industries, Inc. Laser system for improved transbarrier therapeutic radiation delivery
AU3679801A (en) 2000-02-08 2001-08-20 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US6530944B2 (en) 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US6436424B1 (en) 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
FR2806907B1 (fr) 2000-03-31 2003-01-24 Oreal Composition cosmetique a base de nanoparticules et de composes organiques du silicium solubles dans l'eau
US6821509B2 (en) 2000-04-14 2004-11-23 Cosmetica, Inc. Nanoscopic hair care products
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
FR2808999B1 (fr) 2000-05-19 2002-11-01 Oreal Composition cosmetique sous forme de poudre comprenant un liant particulier
FR2808998B1 (fr) 2000-05-19 2002-07-05 Oreal Composition cosmetique de maquillage comprenant une phase liante particuliere
US6403653B1 (en) 2000-06-02 2002-06-11 The United States Of America As Represented By The Secretary Of The Army Active topical skin protectants using reactive nanoparticles
US6410603B1 (en) 2000-06-02 2002-06-25 The United States Of America As Represented By The Secretary Of The Army Active topical skin protectants using combinations of reactive nanoparticles and polyoxometalates or metal salts
US6706032B2 (en) 2000-06-08 2004-03-16 Massachusetts Institute Of Technology Localized molecular and ionic transport to and from tissues
US7008647B2 (en) 2001-04-23 2006-03-07 Nucryst Pharmaceuticals Corp. Treatment of acne
EP2269645A3 (en) 2000-08-16 2011-01-12 The General Hospital Corporation doing business as Massachusetts General Hospital Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
US6942878B2 (en) 2000-09-11 2005-09-13 Showa Denko K.K. Cosmetic composition
FR2815869B1 (fr) 2000-10-27 2006-09-22 Oreal Utilisation de microcapsules thermostabilisatrices pour ameliorer l'activite ou la penetration de principes actifs cosmetiques ou pharmaceutiques
AU2002246587A1 (en) 2000-11-03 2002-08-06 Wm. Marsh Rice University Partial coverage metal nanoshells and method of making same
US20080183162A1 (en) 2000-12-28 2008-07-31 Palomar Medical Technologies, Inc. Methods And Devices For Fractional Ablation Of Tissue
DE10117336A1 (de) 2001-04-06 2002-10-10 Max Planck Gesellschaft Neuartige Lichtschutz- und Hautpflegemittel durch stabilisierte Lichtschutz-Komponenten und Verminderung schädigender Photoprodukte
US6811770B2 (en) 2001-04-10 2004-11-02 L'oreal Two-coat make-up process and a make-up kit containing first and second compositions
JP2004529929A (ja) 2001-04-23 2004-09-30 ニュクリスト ファーマシューティカルズ コーポレーション アポトーシスの誘導およびマトリックスメタロプロテイナーゼの阻害のための金属の使用
IL159131A0 (en) 2001-06-01 2004-05-12 Lipo Chemicals Inc Method of using optically-activated particles in cosmetic preparations
WO2002100444A1 (en) 2001-06-08 2002-12-19 Biosphere Medical Inc. Colloidal metal labelled microparticles, their production and use
FR2827160B1 (fr) 2001-07-16 2007-01-26 Oreal Composition cosmetique comprenant une dispersion de particules
US7018396B2 (en) 2001-08-07 2006-03-28 New England Medical Center Hospitals, Inc. Method of treating acne
US7135054B2 (en) 2001-09-26 2006-11-14 Northwestern University Nanoprisms and method of making them
US6685730B2 (en) 2001-09-26 2004-02-03 Rice University Optically-absorbing nanoparticles for enhanced tissue repair
US6685927B2 (en) 2001-09-27 2004-02-03 Ceramoptec Industries, Inc. Topical application of chromophores for hair removal
US20030156991A1 (en) 2001-10-23 2003-08-21 William Marsh Rice University Optomechanically-responsive materials for use as light-activated actuators and valves
US7037513B1 (en) 2005-01-31 2006-05-02 Aquea Scientific Corporation Bodywash additives
US20030215638A1 (en) 2001-11-05 2003-11-20 Wm. Marsh Rice University Reduced symmetry nanoparticles
MXPA04004288A (es) 2001-11-06 2004-08-11 Phild Co Ltd Locion para la piel, que comprende una dispersion acuosa de particulas ultra-finas de metales nobles.
US20040147984A1 (en) 2001-11-29 2004-07-29 Palomar Medical Technologies, Inc. Methods and apparatus for delivering low power optical treatments
EP1453546A2 (en) 2001-12-04 2004-09-08 Nanospectra Biosciences, Inc. Treatment of angiogenesis disorders using targeted nanoparticles
FR2834453B1 (fr) 2002-01-08 2006-01-06 Oreal Composition de maquillage ou de soin des matieres keratiniques comprenant une huile hydrocarbonee non volatile une phase particulaire et un agent dispersant particulier
US20050177093A1 (en) 2002-03-04 2005-08-11 Barry Hart M. Joint / tissue inflammation therapy and monitoring device
US7081128B2 (en) 2002-03-04 2006-07-25 Hart Barry M Phototherapy device and method of use
WO2004023143A2 (de) 2002-09-03 2004-03-18 Zeptosens Ag Analytische plattform und nachweisverfahren
US20040219179A1 (en) 2002-09-20 2004-11-04 Mcdaniel David H. Skin abrasive agents
US7785623B2 (en) 2002-10-01 2010-08-31 Keller Brian C Compositions and methods useful for the reduction of fine lines and wrinkles
US20040151673A1 (en) 2002-11-21 2004-08-05 Societe L'oreal S.A. Nonaerosol/aerosol dispensing of sunscreen sprays comprising silica microparticles
CA2508359A1 (en) 2002-12-12 2004-06-24 Nanosphere, Inc. Direct snp detection with unamplified dna
WO2004058352A2 (en) 2002-12-20 2004-07-15 Palomar Medical Technologies, Inc. Apparatus for light treatment of acne and other disorders of follicles
US20070231940A1 (en) 2003-01-27 2007-10-04 L'oreal S.A. Composition and method of dyeing keratin fibers comprising luminescent semiconductive nanoparticles
US20040253757A1 (en) 2003-01-27 2004-12-16 Luc Gourlaouen Composition and method of dyeing keratin fibers comprising luminescent semiconductive nanoparticles
US20050186565A1 (en) 2003-02-10 2005-08-25 American Environmental Systems, Inc. Method and spectral/imaging device for optochemical sensing with plasmon-modified polarization
US20040157237A1 (en) 2003-02-10 2004-08-12 Americal Environmental Systems, Inc. Optochemical sensing with multi-band fluorescence enhanced by surface plasmon resonance
US20090326358A1 (en) 2003-02-14 2009-12-31 American Environmental Systems, Inc Non-invasive fast-response biodosimeter
US20050203495A1 (en) 2004-03-10 2005-09-15 American Environmental Systems, Inc. Methods and devices for plasmon enhanced medical and cosmetic procedures
US8118032B2 (en) 2003-02-14 2012-02-21 American Environmental Systems, Inc. Rapid cryo-heating devices and their applications
AU2004223618A1 (en) 2003-03-28 2004-10-07 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Sensor for detecting an analyte using silver nanoparticles
US7659301B2 (en) 2003-04-15 2010-02-09 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
US20050058672A1 (en) 2003-09-14 2005-03-17 Bioderm Research Baby Care Skin Protectant Compositions for Diaper Rash
US20050037034A1 (en) 2003-05-05 2005-02-17 Rhoades Dean L. Method, apparatus, and composition for treating acne
US20040253138A1 (en) 2003-06-16 2004-12-16 American Environmental Systems, Inc. Plasmon enhanced body treatment and bacterial management
WO2004112852A1 (en) 2003-06-23 2004-12-29 Beiersdorf Ag Antimicrobial wounddressing
US20050048546A1 (en) 2003-07-11 2005-03-03 Sharron Penn Multiplexed molecular beacon assay for detection of human pathogens
EP1653876A1 (en) 2003-07-11 2006-05-10 Reliant Technologies, Inc. Method and apparatus for fractional photo therapy of skin
US7226636B2 (en) 2003-07-31 2007-06-05 Los Alamos National Security, Llc Gold-coated nanoparticles for use in biotechnology applications
FR2858213B1 (fr) 2003-08-01 2006-02-10 Oreal Procede de traitement cosmetique de la peau et dispositif pour la mise en oeuvre d'un tel procede
US20050058678A1 (en) 2003-08-01 2005-03-17 Audrey Ricard Two-coat cosmetic product, uses thereof and makeup kit comprising the same
US20050031658A1 (en) 2003-08-01 2005-02-10 L'oreal Cosmetic skin treatment process and device for implementing such a process
US20050031655A1 (en) 2003-08-04 2005-02-10 Schering Plough Healthcare Products, Inc. Emulsion composition
JP4125201B2 (ja) 2003-08-05 2008-07-30 ロレアル 光学的活性物質を内包した多孔質粒子を含有する化粧品組成物
FR2858766B1 (fr) 2003-08-11 2005-11-11 Oreal Composition cosmetique comprenant des particules metalliques stabilisees, eventuellement enrobees
FR2858768B1 (fr) 2003-08-11 2005-11-11 Oreal Composition cosmetique comprenant des particules a structure coeur-enveloppe
FR2858765B1 (fr) 2003-08-11 2005-11-11 Oreal Composition cosmetique comprenant des particules a structure coeur-enveloppe
FR2858767B1 (fr) 2003-08-11 2005-11-11 Oreal Composition cosmetique comprenant des particules metalliques passivees, eventuellement enrobees
US20050044642A1 (en) 2003-09-02 2005-03-03 Montagne Jeunesse Ltd Hair colouring composition
US7462496B2 (en) 2003-09-08 2008-12-09 American Environmental System, Inc. Plasmon-enhanced marking of fragile materials and other applications thereof
US7704754B2 (en) 2004-01-27 2010-04-27 American Environmental Systems, Inc. Method of plasmon-enhanced properties of materials and applications thereof
DE10342258A1 (de) 2003-09-11 2005-04-07 Josef Peter Prof. Dr.med. Guggenbichler Antimikrobiell wirkendes Präparat zur äußerlichen Anwendung
JP2007509098A (ja) 2003-10-24 2007-04-12 ウエラ　アクチェンゲゼルシャフト 毛髪または皮膚の酸化的処理のための組成物、および毛髪のパーマネント変形のための固定組成物および方法
DE602004016022D1 (de) 2003-10-30 2008-10-02 Mcneil Ppc Inc Zusammengesetzte materialien aus metall beladenen abgeblätterten nanoteilchen
DE10351611A1 (de) 2003-11-05 2005-08-11 Guggenbichler, Josef-Peter, Prof.Dr. Verfahren zur Herstellung einer nanoskaliges elementares Silber enthaltenden flüssigen Phase hoher Reinheit
FR2861986B1 (fr) 2003-11-07 2007-12-14 Oreal Composition de maquillage comprenant une emulsion
WO2005060610A2 (en) 2003-12-11 2005-07-07 The Trustees Of Columbia University In The City Ofnew York Nano-sized particles, processes of making, compositions and uses thereof
US20050137656A1 (en) 2003-12-23 2005-06-23 American Environmental Systems, Inc. Acoustic-optical therapeutical devices and methods
US7328708B2 (en) 2003-12-23 2008-02-12 United Laboratories & Manufacturing, Llc LED multiplex source and method of use of for sterilization, bioactivation and therapy
US7492458B2 (en) 2004-01-05 2009-02-17 American Environmental Systems, Inc. Plasmon-enhanced display technologies
DE102004002990A1 (de) 2004-01-21 2005-08-18 Robert Dr. Simmoteit Material und Verfahren zum Stoffaustausch und Stofftransfer
FR2865386B1 (fr) 2004-01-27 2006-03-31 Oreal Composition cosmetique a poudre compacte
US20050186235A1 (en) 2004-01-27 2005-08-25 Guenaelle Martin Compact powder cosmetic compositions with a solid fatty phase
US20050187128A1 (en) 2004-01-27 2005-08-25 Guenaelle Martin Cosmetic composition of the compact powder type
FR2865385B1 (fr) 2004-01-27 2014-04-04 Oreal Composition cosmetique de type poudre compacte a phase grasse solide
EP1426033A3 (de) 2004-01-29 2004-09-15 Wella Aktiengesellschaft Emulsionsförmiges Haarbehandlungsmittel mit Gehalt an Feststoffpartikeln
KR20050080805A (ko) 2004-02-11 2005-08-18 주식회사 태평양 은/고분자 나노복합 구형체 및 그 제조방법, 및 이를함유하는 화장료 조성물
US20050220741A1 (en) 2004-03-22 2005-10-06 Christophe Dumousseaux Cosmetic composition comprising concave particles
US7131446B2 (en) 2004-03-25 2006-11-07 Tang Kenneth Y Light-triggered tattoo process
US20080241262A1 (en) 2004-03-29 2008-10-02 The University Of Houston System Nanoshells and Discrete Polymer-Coated Nanoshells, Methods For Making and Using Same
WO2005096979A1 (en) 2004-04-01 2005-10-20 The General Hospital Corporation Method and apparatus for dermatological treatment and tissue reshaping
US20090130445A1 (en) 2004-04-05 2009-05-21 Henryk Malak Nanostructured enhancer
US7829073B2 (en) 2004-04-06 2010-11-09 L'oreal S.A. Anhydrous cosmetic compositions comprising at least one polymeric gelling agent, at least one non-volatile oil, and poly(methyl methacrylate) particles
US7276088B2 (en) 2004-04-15 2007-10-02 E.I. Du Pont De Nemours And Company Hair coloring and cosmetic compositions comprising carbon nanotubes
US20060257336A1 (en) 2004-04-19 2006-11-16 Veronique Ferrari Cosmetic composition comprising silica particles, reflecting particles, and at least one polymer, preparative processes, and uses thereof
FR2869803B1 (fr) 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
FR2873028B1 (fr) 2004-07-13 2008-04-04 Oreal Composition photoprotectrice aqueuse contenant des nanopigments d'oxyde metallique hydrophiles et un homopolymere de vinylpyrrolidone ; utilisations
FR2873020A1 (fr) 2004-07-13 2006-01-20 Oreal Composition photoprotectrice aqueuse contenant des nanopigments d'oxyde metallique hydrophiles et un polyalkylglycol de faible masse moleculaire; utilisations
KR100684985B1 (ko) 2004-07-30 2007-02-20 한국화학연구원 자가조형성 퍼머제
CA2577117A1 (en) 2004-08-13 2006-12-21 William Marsh Rice University Method and system for optimizing surface enhanced raman scattering
US20060078578A1 (en) 2004-10-07 2006-04-13 Sandewicz Robert W Cosmetic compositions with montmorillonite stabilizing agent
US20060083762A1 (en) 2004-10-13 2006-04-20 Gaelle Brun Uses of compositions comprising electrophilic monomers and micro-particles or nanoparticles
DE202004017052U1 (de) 2004-11-02 2005-06-09 Riesinger, Birgit Vorrichtung zur Wundbehandlung unter Einsatz von Unterdruck
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
US7780955B2 (en) 2004-11-12 2010-08-24 L'oreal Cosmetic composition with a lightening effect
EP1819277A4 (en) 2004-11-12 2010-05-05 Ltd Kpe NANOTE PARTICLE-MEDIATED ULTRASOUND THERAPY AND DIAGNOSTIC IMAGE DISPLAY
CA2589875A1 (en) 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth
DE102005007482A1 (de) 2005-02-17 2006-09-14 Merck Patent Gmbh Zubereitung enthaltend nanopartikuläres UV-Schutzmittel
US20070196305A1 (en) 2005-03-01 2007-08-23 Hong Wang Method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom
ES2350493T3 (es) 2005-03-23 2011-01-24 Dsm Ip Assets B.V. Partículas de óxido metálico, recubiertas con un cromóforo.
US7666494B2 (en) 2005-05-04 2010-02-23 3M Innovative Properties Company Microporous article having metallic nanoparticle coating
WO2006122222A2 (en) 2005-05-11 2006-11-16 Georgia Tech Research Corporation Shape tunable plasmonic nanoparticles
WO2007002567A2 (en) 2005-06-23 2007-01-04 Nanosphere, Inc. Selective isolation and concentration of nucleic acids from complex samples
KR100732249B1 (ko) 2005-07-18 2007-06-27 한국생명공학연구원 금 및/또는 은 나노입자를 함유하는 화장료용 안료 조성물
US20070065387A1 (en) 2005-09-16 2007-03-22 Beck William A Method for enhancing the effect of particulate benefit agents
US20070078290A1 (en) 2005-09-30 2007-04-05 Esenaliev Rinat O Ultrasound-based treatment methods for therapeutic treatment of skin and subcutaneous tissues
ES2391729T3 (es) * 2005-10-14 2012-11-29 Vive Crop Protection Inc. Nanopartículas compuestas, nanopartículas y métodos para la producción de las mismas
KR20080063835A (ko) 2005-10-26 2008-07-07 시바 홀딩 인코포레이티드 모발 염색 방법
US20080288007A1 (en) 2005-10-28 2008-11-20 United Laboratories & Manufacturing, Llc Hygienic-Therapeutic Multiplex Devices
US20070158611A1 (en) * 2005-11-08 2007-07-12 Oldenburg Steven J Compositions comprising nanorods and methods of making and using them
CA2629193C (en) 2005-11-18 2016-03-29 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
US20070125383A1 (en) 2005-12-02 2007-06-07 Ko Chuan T Facial mask
FR2894467B1 (fr) 2005-12-08 2008-02-15 Oreal Composition cosmetique foisonnee de faible densite
EP1959914B1 (en) 2005-12-09 2014-05-21 DSM IP Assets B.V. Cosmetic or dermatological compositions comprising modified titanium dioxide particles
US20070160896A1 (en) 2006-01-09 2007-07-12 American Environmental Systems, Inc Plasmonic fuel cell
US8518445B2 (en) 2006-01-20 2013-08-27 Research Foundation Of The City University Of New York Changing skin-color perception using quantum and optical principles in cosmetic preparations
US20070208400A1 (en) 2006-03-01 2007-09-06 The General Hospital Corporation System and method for providing cell specific laser therapy of atherosclerotic plaques by targeting light absorbers in macrophages
US7790066B2 (en) 2006-03-03 2010-09-07 William Marsh Rice University Nanorice particles: hybrid plasmonic nanostructures
WO2007106415A2 (en) 2006-03-10 2007-09-20 Massachusetts Institute Of Technology Triggered self-assembly conjugates and nanosystems
WO2007128066A1 (en) 2006-05-04 2007-11-15 University Of South Australia Drug release from nanoparticle-coated capsules
WO2007149387A2 (en) 2006-06-19 2007-12-27 Northwestern University Ph-controlled photosynthesis of silver nanoprisms
US8178202B2 (en) 2006-06-21 2012-05-15 William Marsh Rice University Nonconcentric nanoshells with offset core in relation to shell and method of using the same
JP4650354B2 (ja) 2006-06-28 2011-03-16 住友化学株式会社 不飽和アルデヒド及び／又は不飽和カルボン酸製造用触媒の再生方法、並びに不飽和アルデヒド及び／又は不飽和カルボン酸の製造方法
KR100815182B1 (ko) 2006-07-05 2008-03-19 주식회사 바이오프로젠 금속 나노 입자를 이용한 미생물 셀룰로오스를 주성분으로하는 화장품용 착색 마스크 팩 및 이의 제조 방법
GB0712287D0 (en) 2007-06-22 2007-08-01 Ucl Business Plc Antimicrobial Conjugates
JP2008069097A (ja) 2006-09-13 2008-03-27 Aputo Kk 遷移金属微粒子を含むｍｍｐ阻害剤
US8285391B2 (en) 2006-09-25 2012-10-09 American Environmental Systems, Inc. Hygienic-therapeutic conductive far-infrared devices
DE102006049108B4 (de) 2006-10-13 2019-05-02 Agxx Intellectual Property Holding Gmbh Bioaktive, rutheniumhaltige Beschichtungen, deren Verwendung und Verfahren zur Beschichtung einer Vorrichtung
JP4958082B2 (ja) * 2006-10-26 2012-06-20 独立行政法人産業技術総合研究所 Ｌｐｒセンサ用ナノ粒子、ナノ粒子の製造方法、スラリー、塗料、塗膜及びｌｐｒセンサ
WO2008052198A2 (en) 2006-10-26 2008-05-02 Reliant Technologies, Inc. Methods of increasing skin permeability by treatment with electromagnetic radiation
WO2008064357A2 (en) 2006-11-22 2008-05-29 University Of Florida Research Foundation, Inc. Nanoparticles for protection of cells from oxidative stress
TW200846027A (en) 2006-12-20 2008-12-01 Avon Prod Inc Nanocomposite pigments in a topical cosmetic application
WO2008079898A1 (en) 2006-12-20 2008-07-03 Pharmwest, Inc. Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions
TW200846026A (en) 2006-12-20 2008-12-01 Avon Prod Inc Nanocomposite pigments in a topical cosmetic application
WO2008127743A2 (en) 2007-01-05 2008-10-23 William Marsh Rice University Composition for targeted drug delivery and controlled release
JP2010517996A (ja) 2007-02-01 2010-05-27 ソル − ゲル テクノロジーズ リミテッド 過酸化物及びレチノイドを含む局所適用用組成物
WO2008108980A2 (en) 2007-03-01 2008-09-12 Nanospectra Biosciences, Inc. Devices and methods for extracorporeal ablation of circulating cells
WO2008106966A1 (en) 2007-03-06 2008-09-12 Christiansen Kaare A method for non-therapeutic or therapeutic photodynamic skin treatment
US9095522B2 (en) 2007-03-19 2015-08-04 Guerry L. Grune High SPF transparent or translucent, cytoprotective, biodegradable, UV radiation resistant compositions
US20080234535A1 (en) 2007-03-23 2008-09-25 American Environmental Systems, Inc Device and method for thrombosis and pulmonary embolism
KR20080004173U (ko) 2007-03-23 2008-09-26 주식회사 세전사 등기구
US9358292B2 (en) 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
JP2010524591A (ja) 2007-04-19 2010-07-22 ザ ファウンドリー， インコーポレイテッド 汗の産生を低減するための方法および装置
DE102007020554A1 (de) 2007-04-27 2008-10-30 Henkel Ag & Co. Kgaa Nukleinsäurehaltige kosmetische und/oder pharmazeutische Zubereitungen zur Behandlung epithelialen Deckgewebes
ES2454974T3 (es) 2007-06-27 2014-04-14 The General Hospital Corporation Aparato para la inhibición óptica de la terapia fotodinámica
US20090012445A1 (en) 2007-07-03 2009-01-08 Henryk Malak Device and method for In-Situ tissue regeneration
TW200902073A (en) 2007-07-06 2009-01-16 Kuan-Jiuh Lin Cosmetic composition
US8268638B2 (en) 2007-07-18 2012-09-18 Advantageous Systems, Llc Methods and apparatuses for detecting analytes in biological fluid of an animal
US9023372B2 (en) 2007-07-18 2015-05-05 University Of Maryland Metal-enhanced fluorescence nanoparticles
KR20100051680A (ko) * 2007-07-24 2010-05-17 노오쓰웨스턴 유니버시티 코팅된 콜로이드 재료
US20090053268A1 (en) 2007-08-22 2009-02-26 Depablo Juan J Nanoparticle modified lubricants and waxes with enhanced properties
FR2920965B1 (fr) 2007-09-13 2011-03-18 Lvmh Rech Utilisation de nanoparticules d'oxydes de titane dopes a l'azote comme agent de protection contre les radiations ultraviolettes
US20090071168A1 (en) 2007-09-17 2009-03-19 American Environmental Systems, Inc. Device and methods for internal cooling of an integrated circuit (IC)
WO2009040811A2 (en) 2007-09-24 2009-04-02 Bar-Ilan University Polymer nanoparticles coated by magnetic metal oxide and uses thereof
WO2009044389A2 (en) 2007-10-04 2009-04-09 National University Of Ireland, Galway A process for synthesising silver nanoparticles
US20100298760A1 (en) 2007-11-05 2010-11-25 Bernat Olle Methods, kits, and compositions for administering pharmaceutical compounds
US20090123509A1 (en) 2007-11-08 2009-05-14 Cory Berkland Biodegradable Colloidal Gels as Moldable Tissue Engineering Scaffolds
WO2009064964A2 (en) 2007-11-15 2009-05-22 The University Of California Switchable nano-vehicle delivery systems, and methods for making and using them
CN101182578B (zh) * 2007-11-19 2011-04-20 中国科学院上海微系统与信息技术研究所 基于纳米金探针的基因芯片的dna检测方法
US9186317B2 (en) 2007-11-26 2015-11-17 Stc.Unm Active nanoparticles and method of using
WO2009080952A2 (fr) 2007-12-05 2009-07-02 L'oreal Procédé cosmétique de maquillage et/ou de soin utilisant une résine de siloxane et une huile non volatile
TWI411448B (zh) 2007-12-27 2013-10-11 Avon Prod Inc 適合用於化妝品之光學模糊色素組合物
TWI468185B (zh) 2007-12-27 2015-01-11 Avon Prod Inc 適合用於化妝品組合物之凝膠技術
CN101951929A (zh) 2007-12-28 2011-01-19 水株式会社 用于治疗或预防的外用剂
US20090177122A1 (en) 2007-12-28 2009-07-09 Celleration, Inc. Methods for treating inflammatory skin disorders
EP2238451A4 (en) 2008-01-03 2011-02-23 Univ Singapore NANOSTRUCTURES, METHOD FOR THE PRODUCTION THEREOF AND USES THEREOF
ES2326721B1 (es) 2008-01-04 2010-07-16 Endor Nanotechnologies, S.L. Conjugado de acido hialuronico para el tratamiento cosmetico y procedimiento de preparacion.
US9056053B2 (en) 2008-01-08 2015-06-16 Avon Products, Inc Nanoparticle compositions providing enhanced color for cosmetic formulations
WO2009091597A2 (en) 2008-01-16 2009-07-23 Nanospectra Biosciences, Inc. Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy
JP2009168681A (ja) * 2008-01-17 2009-07-30 Fujifilm Corp 免疫学的検出方法
US20100284924A1 (en) 2008-01-23 2010-11-11 The Regents Of The University Of California Nano-devices having impellers for capture and release of molecules
DE102008008522A1 (de) 2008-02-11 2009-08-13 Magforce Nanotechnologies Ag Implantierbare Nanopartikel-enthaltende Produkte
EP2090285A1 (en) 2008-02-18 2009-08-19 B.R.A.I.N. Biotechnology Research and Information Network AG Means and methods for controlling commensales
WO2009105209A1 (en) 2008-02-19 2009-08-27 Health Research, Inc. Silica nanoparticles postloaded with photosensitizers for drug delivery in photodynamic therapy
DE102008013143A1 (de) 2008-03-07 2009-09-10 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Silberhaltiges Beschichtungsmittel auf der Basis von Alkoxysilanen, löslichen Silbersalzen und Aminverbindungen sowie dessen Herstellung
WO2009117124A1 (en) 2008-03-19 2009-09-24 Nanospectra Biosciences, Inc. Narrowband imaging using near-infrared absorbing nanoparticles
CA2906990A1 (en) 2008-04-04 2009-10-08 Duke University Non-invasive systems and methods for in-situ photobiomodulation
US20110039078A1 (en) * 2008-04-25 2011-02-17 Margaret Elizabeth Brennan Fournet Ink comprising nanostructures
CA2726944A1 (en) 2008-06-05 2009-12-10 Richard E. Davidson Acne treatment compositions comprising nanosilver and uses
US8130438B2 (en) 2008-07-03 2012-03-06 Ajjer Llc Metal coatings, conductive nanoparticles and applications of the same
US20100016782A1 (en) 2008-07-16 2010-01-21 John Erich Oblong Method of Regulating Hair Growth
US20100056485A1 (en) 2008-08-28 2010-03-04 Snu R&Db Foundation Nanosoap containing silver nanoparticles
US20100057068A1 (en) 2008-08-29 2010-03-04 Kwangyeol Lee Gold nanostructure and methods of making and using the same
CA2972242A1 (en) 2008-09-18 2010-04-22 Auspex Pharmaceuticals, Inc. Benzoquinoline inhibitors of vesicular monoamine transporter 2
WO2010048623A2 (en) 2008-10-26 2010-04-29 Board Of Regents, The University Of Texas Systems Medical and imaging nanoclusters
US20100104652A1 (en) 2008-10-27 2010-04-29 University Of Arkansas Use of advanced nanomaterials for increasing sepecific cell functions
WO2010056881A1 (en) * 2008-11-12 2010-05-20 Solutions Biomed, Llc Multi-chamber container system for storing and mixing liquids
US20100119610A1 (en) 2008-11-12 2010-05-13 Concurrent Analytical, Inc. Packaged pegylated gold nanoparticles
AU2009314147B2 (en) 2008-11-12 2015-12-24 The Trustees Of The University Of Pennsylvania Fibroblast growth factor-9 promotes hair follicle regeneration after wounding
EP2376215B1 (en) 2008-12-11 2018-10-10 The Regents of The University of California Filtration membrane
WO2010073260A1 (en) 2008-12-26 2010-07-01 Jawaharlal Nehru Centre For Advanced Scientific Research Sers active paper substrate, a process and a method thereof
EA019739B1 (ru) 2009-02-10 2014-05-30 Скайлайт Текнолоджи Лимитед Фармацевтическая композиция и способ увеличения роста волос
JP2012521962A (ja) 2009-03-27 2012-09-20 ロレアル 化粧用の紡錘状粒子を含む粒子組成物
EP2410973A1 (en) 2009-03-27 2012-02-01 L'Oréal Liquid composition containing fusiform particles for cosmetic use
DE102009002267A1 (de) 2009-04-07 2010-10-14 Henkel Ag & Co. Kgaa Pulverförmige Zusammensetzung zur Form- und Glanzgebung keratinischer Fasern
WO2010116345A1 (en) 2009-04-08 2010-10-14 National University Of Ireland, Galway Silver nanoplates
IE20100204A1 (en) * 2009-04-08 2010-11-10 Nat Univ Ireland Silver nanoplates
WO2010123993A1 (en) 2009-04-21 2010-10-28 Tuan Vo-Dinh Non-invasive energy upconversion methods and systems for in-situ photobiomodulation
EP2435125B1 (en) 2009-05-26 2016-09-14 The General Hospital Corporation Apparatus for dermal delivery of a substance
JP2010275566A (ja) 2009-05-26 2010-12-09 Panasonic Electric Works Co Ltd 金属微粒子生成装置及びそれを備えた髪ケア装置
US9504824B2 (en) 2009-06-23 2016-11-29 Board Of Regents, The University Of Texas System Noninvasive therapies in the absence or presence of exogenous particulate agents
EP2459268B1 (en) 2009-07-30 2013-05-29 Alma Lasers Ltd A sonotrode
JP5744033B2 (ja) 2009-09-09 2015-07-01 キユーデイー・ビジヨン・インコーポレーテツド ナノ粒子を含む粒子、それの使用および方法
US8591924B2 (en) 2009-09-23 2013-11-26 Avon Products, Inc. High-coverage and natural-looking cosmetic compositions and uses thereof
US8652534B2 (en) 2009-10-14 2014-02-18 Berry Pharmaceuticals, LLC Compositions and methods for treatment of mammalian skin
US20110097285A1 (en) 2009-10-28 2011-04-28 American Environmental Systems, Inc. Multiplex dentifrice compositions
CN102870235B (zh) 2009-11-10 2016-11-23 免疫之光有限责任公司 用于从包括用于上变频的射频、微波能量和磁感应源的各种能量源产生发射光的上下变频系统
US20110111002A1 (en) 2009-11-12 2011-05-12 Calin Viorel Pop Transport and delivery of glutathione into human cells using gold nanoparticles
FR2952533B1 (fr) 2009-11-13 2012-01-13 Oreal Composition cosmetique pour le conditionnement des cheveux contenant un melange de particules creuses, d'amidon et de tensioactif cationique
BR112012011714A2 (pt) 2009-11-16 2016-03-01 Basf Se método para proteger um objeto contra radiação uv, método para fabricar um nanocompósito de óxido metálico, e, nanocompósito de óxido metálico
US9308582B2 (en) 2009-12-24 2016-04-12 Yi Sun Solution stable and chemically reactive metallic nanoparticles
KR20130020742A (ko) 2010-02-07 2013-02-27 제이.피.엠.이.디. 리미티드 모낭 표적 조성물
ES2384060B1 (es) * 2010-03-24 2013-09-23 Lipotec S.A. Cápsulas de nanopartículas lipídicas.
JP5769795B2 (ja) 2010-03-31 2015-08-26 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ 口腔ケア組成物
MX2012010608A (es) 2010-03-31 2012-10-03 Colgate Palmolive Co Composicion para el cuidado oral.
WO2011127061A1 (en) 2010-04-05 2011-10-13 Nanospectra Biosciences, Inc. Enhancement of radiation therapy by targeted high-z nanoparticles
US20110306955A1 (en) 2010-04-12 2011-12-15 Advalight Aps Multiwavelength laser apparatus for skin treatment
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
PT3213738T (pt) 2010-08-27 2020-03-31 Sebacia Inc Composições e métodos para modulação térmica direcionada
US10307372B2 (en) 2010-09-10 2019-06-04 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
FR2964663B1 (fr) 2010-09-14 2013-10-11 Oreal Composition cosmetique comprenant une matiere colorante, ladite matiere colorante et procede de traitement cosmetique
ES2386177B1 (es) 2010-09-21 2013-09-23 Lipotec, S.A. Nanocapsulas conteniendo microemulsiones
AU2011324794B2 (en) 2010-11-02 2015-09-03 Indian Institute Of Technology, Delhi Blue coloured aqueous dispersion of silver nanoparticles a process for preparation and compositions thereof
FR2967348B1 (fr) 2010-11-17 2013-05-10 Oreal Composition cosmetique pour le contour des yeux
WO2012081011A1 (en) 2010-12-14 2012-06-21 Slender Medical Ltd. Ultrasound skin treatment
US8197471B1 (en) 2011-02-14 2012-06-12 Samuel Harry Tersigni Core-excited nanoparticles and methods of their use in the diagnosis and treatment of disease
US8784895B2 (en) 2011-03-15 2014-07-22 Northwestern University Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same
TWI458504B (zh) 2011-05-02 2014-11-01 Univ Nat Cheng Kung 經皮藥物釋放貼片及利用近紅外光控制其藥物釋放之方法
US9241921B2 (en) 2011-05-02 2016-01-26 Pankaj Modi Photosensitizer composition for treating skin disorders
US9956028B2 (en) 2011-05-09 2018-05-01 Innovolink, Llc Apparatus and method for heating biological targets
EP2718433A4 (en) 2011-06-10 2015-07-29 Univ New York State Res Found METHOD AND DEVICE FOR THE NONINVASIVE ACOUSTIC STIMULATION OF STEM CELLS AND PRECIPITATING CELLS IN A PATIENT
WO2012174466A2 (en) 2011-06-17 2012-12-20 Annuary Healthcare, Inc. Nanoscale particle formulations and methods
DK2785310T3 (da) 2011-11-30 2018-01-29 Institució Catalana De Recerca I Estudis Avançats Fremgangsmåde til øget fotoepilering baseret på metalliske nanopartikler.
WO2013107000A1 (en) 2012-01-17 2013-07-25 L'oreal Colour changing composition
WO2013106999A1 (en) 2012-01-17 2013-07-25 L'oreal Colour changing composition with alcohol
WO2013107002A1 (en) 2012-01-17 2013-07-25 L'oreal Colour changing composition with polyols
WO2013106998A1 (en) 2012-01-17 2013-07-25 L'oreal Colour changing composition in o/w emulsion form
WO2013107001A1 (en) 2012-01-17 2013-07-25 L'oreal Colour changing composition with uv filter(s)
WO2013106996A1 (en) 2012-01-17 2013-07-25 L'oreal Colour changing composition in gel form
US20130323305A1 (en) 2012-04-20 2013-12-05 The General Hospital Corporation Compositions and methods comprising energy absorbing materials for follicular delivery
US20130315999A1 (en) 2012-04-20 2013-11-28 The General Hospital Corporation Compositions and methods comprising energy absorbing compoundfs for follicular delivery
EP2841049B1 (en) 2012-04-26 2021-11-10 L'Oréal Cosmetic composition comprising mattifying fillers and a silane
US9333258B2 (en) 2012-05-08 2016-05-10 The Regents Of The University Of California Fine spatiotemporal control of fat removal using NIR light
US10154881B2 (en) 2012-08-10 2018-12-18 Arizona Board Of Regents For And On Behalf Of Arizona State University Methods and compositions for tissue adhesives
WO2014052973A1 (en) 2012-09-28 2014-04-03 Stelo Technologies Methods of making silver nanoparticles and their applications
AU2013329450B2 (en) 2012-10-11 2017-06-22 Coronado Aesthetics, Llc Silver nanoplate compositions and methods
CA2889423A1 (en) 2012-10-26 2014-05-01 Nanocomposix, Inc. Metastable silver nanoparticle composites
US20140120167A1 (en) 2012-10-30 2014-05-01 William Marsh Rice University Multifunctional chemo- and mechanical therapeutics
US9624282B2 (en) 2012-11-26 2017-04-18 The Curators Of The University Of Missouri Microdystrophin peptides and methods for treating muscular dystrophy using the same
PL2941163T3 (pl) 2013-01-07 2021-07-19 Filip Sedic Oczyszczacz do skóry
EP2968889A4 (en) 2013-03-15 2016-11-09 Univ California METHOD FOR DISTRIBUTING NANOHOUTS IN EXTINGUITS
US20150045723A1 (en) 2013-08-09 2015-02-12 Dilip Paithankar Compositions, methods and apparatus for use with energy activatible materials
US20160287741A1 (en) 2013-11-18 2016-10-06 Sienna Labs, Inc. Metastable silver nanoparticle composites with color indicating properties
US9279270B1 (en) 2014-01-08 2016-03-08 John Christian Treister System for affixing a blanket to ground
CA2935865A1 (en) 2014-01-10 2015-07-16 Sebacia, Inc. Treatment intervals for use of compositions comprising energy absorbing materials for dermatological applications
JP2017501856A (ja) 2014-01-10 2017-01-19 セバシア，インコーポレイテッド 表面下の吸収材アレイおよび光照射治療
EP3092194A4 (en) 2014-01-10 2018-06-13 Sebacia, Inc. Particle containers and delivery applicators
WO2016075747A1 (ja) 2014-11-10 2016-05-19 日本たばこ産業株式会社 非燃焼型香味吸引器及びパッケージ
BR112018009662A2 (pt) 2015-11-13 2018-11-13 Sebacia Inc métodos de tratamento de doenças da pele usando nanopartículas plasmônicas

Also Published As

Publication number Publication date
IL305614B1 (en) 2024-05-01
IL238112B (en) 2020-06-30
EP2906286B1 (en) 2017-06-14
JP6574867B2 (ja) 2019-09-11
AU2013329450B2 (en) 2017-06-22
AU2024227663B2 (en) 2026-04-02
KR102154207B1 (ko) 2020-09-10
AU2017219126B2 (en) 2018-07-05
IL316627A (en) 2024-12-01
JP2018172795A (ja) 2018-11-08
US20200306294A1 (en) 2020-10-01
AU2018241065B2 (en) 2020-04-02
US10688126B2 (en) 2020-06-23
WO2014058904A1 (en) 2014-04-17
US20230139868A1 (en) 2023-05-04
HK1212931A1 (zh) 2016-06-24
IL311688A (en) 2024-05-01
CN108480620A (zh) 2018-09-04
JP2020020044A (ja) 2020-02-06
US9249334B2 (en) 2016-02-02
US20160101130A1 (en) 2016-04-14
AU2022259793C1 (en) 2024-10-31
RU2015112182A (ru) 2016-12-10
EP3272388A1 (en) 2018-01-24
IL296593A (en) 2022-11-01
EP2906286A1 (en) 2015-08-19
KR20150066589A (ko) 2015-06-16
AU2020204436A1 (en) 2020-07-23
US20240293597A1 (en) 2024-09-05
CN104822412A (zh) 2015-08-05
AU2013329450A1 (en) 2015-05-14
JP2016500679A (ja) 2016-01-14
IL296593B2 (en) 2024-04-01
IL238112A0 (en) 2015-05-31
IL311688B1 (en) 2024-12-01
RU2646809C2 (ru) 2018-03-07
US11583553B2 (en) 2023-02-21
IL274971B (en) 2022-11-01
AU2022259793B2 (en) 2024-08-08
US20140105982A1 (en) 2014-04-17
IL296593B1 (en) 2023-12-01
AU2020204436B2 (en) 2022-07-28
IL274971A (en) 2020-07-30
BR112015008063A2 (pt) 2021-08-24
IL274971B2 (en) 2023-03-01
AU2024227663A1 (en) 2024-11-14
HK1254167A1 (zh) 2019-07-12
AU2017219126A1 (en) 2017-09-14
AU2018241065A1 (en) 2018-10-25
ES2629903T3 (es) 2017-08-16
US20170087183A1 (en) 2017-03-30
IL305614A (en) 2023-11-01
US20150225599A1 (en) 2015-08-13
US9212294B2 (en) 2015-12-15
PL2906286T3 (pl) 2018-03-30
US20160075851A1 (en) 2016-03-17
IL305614B2 (en) 2024-09-01
IL311688B2 (en) 2025-04-01
CN104822412B (zh) 2018-05-01
KR20200106984A (ko) 2020-09-15
US9526745B2 (en) 2016-12-27
EP2906286A4 (en) 2016-07-20
CA2887687A1 (en) 2014-04-17
US12029831B2 (en) 2024-07-09
AU2022259793A1 (en) 2022-12-01
MX2015004524A (es) 2015-09-25
JP6325552B2 (ja) 2018-05-16

Similar Documents

Publication Publication Date Title
US12029831B2 (en) Silver nanoplate compositions and methods
AU2026203055A1 (en) Silver nanoplate compositions and methods
HK1212931B (en) Silver nanoplate compositions and methods